These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2100710)

  • 1. Influence of exogenous protease inhibitor (Bowmann-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Hurwitz N; Bar-Khayim Y; Birk Y
    Contrib Nephrol; 1990; 83():183-90. PubMed ID: 2100710
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial gentamicin activity in the presence of exogenous protease inhibitor (Bowman-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Bar-Khayim Y; Birk Y
    Nephron; 1992; 61(1):68-72. PubMed ID: 1528344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis.
    Ware JH; Wan XS; Newberne P; Kennedy AR
    Dig Dis Sci; 1999 May; 44(5):986-90. PubMed ID: 10235608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced urinary trypsin inhibitory activity in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Nitsan Z; Hurwitz N; Miskin A; Bar-Khayim Y; Birk Y
    Clin Chim Acta; 1988 Sep; 176(3):333-42. PubMed ID: 3180482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
    Evans SM; Van Winkle T; Szuhaj B; Michel KE; Kennedy AR
    Radiat Res; 1992 Nov; 132(2):259-62. PubMed ID: 1438709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
    Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interaction between gentamicin and pyridoxal-5-phosphate on functional and metabolic parameters in kidneys of female Sprague-Dawley rats.
    Smetana S; Khalef S; Kopolovic G; Bar-Khayim Y; Birk Y; Kacew S
    Ren Fail; 1992; 14(2):147-53. PubMed ID: 1636020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. I. Subtotal surgical nephrectomy.
    Carver MP; Shy-Modjeska JS; Brown TT; Rogers RA; Riviere JE
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):251-63. PubMed ID: 4024115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor.
    Witschi H; Kennedy AR
    Carcinogenesis; 1989 Dec; 10(12):2275-7. PubMed ID: 2591017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside nephrotoxicity.
    Kaloyanides GJ; Pastoriza-Munoz E
    Kidney Int; 1980 Nov; 18(5):571-82. PubMed ID: 7463954
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity.
    Morales AI; Buitrago JM; Santiago JM; Fernández-Tagarro M; López-Novoa JM; Pérez-Barriocanal F
    Antioxid Redox Signal; 2002 Dec; 4(6):893-8. PubMed ID: 12573138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of gentamicin nephrotoxicity and effect of concurrent cephalothin in the rat.
    Sugarman A; Brown RS; Silva P; Rosen S
    Nephron; 1983; 34(4):239-47. PubMed ID: 6877460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
    Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin nephrotoxicity in cadmium, lead and mercury pretreated rats.
    Viau C; Bernard A; Lauwerys RR; Tulkens P; Laurent G; Maldague P
    Toxicology; 1983 May; 27(1):15-25. PubMed ID: 6437016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K; Yano T; Sadzuka Y; Sugiyama T; Seki T; Asano R
    Oncol Rep; 2005 Jun; 13(6):1247-50. PubMed ID: 15870950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
    Samadian T; Dehpour AR; Amini S; Nouhnejad P
    Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A; López-Novoa JM; Arévalo M
    Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole protection of rats against gentamicin-induced nephrotoxicity.
    Elfarra AA; Duescher RJ; Sausen PJ; O'Hara TM; Cooley AJ
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1238-44. PubMed ID: 7882190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium supplementation and thyroid hormone protect against gentamicin-induced inhibition of proximal tubular Na+,K(+)-ATPase activity and other renal functional changes.
    Fukuda Y; Eklöf AC; Malmborg AS; Aperia A
    Acta Physiol Scand; 1992 Jun; 145(2):93-8. PubMed ID: 1322021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal uptake and nephrotoxicity of gentamicin during urinary alkalinization in rats.
    Chiu PJ; Miller GH; Long JF; Waitz JA
    Clin Exp Pharmacol Physiol; 1979; 6(3):317-26. PubMed ID: 38026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.